| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.54B | — | +13.5% |
| R&D Expense | $705.0M | — | +6.3% |
| SG&A Expense | $216.0M | — | +1.9% |
| Operating Income | $338.0M | — | +766.7% |
| Interest Expense | $29.0M | — | +0.0% |
| Pre-tax Income | $355.0M | — | +244.7% |
| Income Tax | $133.0M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $559.0M | -62.8% | -42.5% |
| Short-term Investments | $3.79B | -3.8% | -45.8% |
| Accounts Receivable | $1.57B | -32.5% | +15.6% |
| Current Assets | $6.59B | -21.8% | -33.8% |
| Total Assets | $16.09B | -11.0% | -6.5% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $696.0M | — | +52.3% |
| Capital Expenditures | $80.0M | — | +122.2% |
| Investing Cash Flow | $97.0M | — | +118.5% |
| Financing Cash Flow | -$1.73B | — | -245.9% |
| Free Cash Flow | $616.0M | — | +46.3% |
| +280.0% |
| Net Income | $222.0M | — | +226.5% |
| EPS (Basic) | $0.87 | — | +248.0% |
| EPS (Diluted) | $0.87 | — | +248.0% |
| $6.54B |
| +2.5% |
| +35.6% |
| Long-term Debt | $2.99B | +0.0% | +0.1% |
| Total Liabilities | $9.41B | -8.4% | +13.4% |
| Stockholders' Equity | $6.68B | -14.4% | -25.1% |